Christopher B. Umbricht

24.8k total citations · 1 hit paper
80 papers, 4.9k citations indexed

About

Christopher B. Umbricht is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Christopher B. Umbricht has authored 80 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 29 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Cancer Research. Recurrent topics in Christopher B. Umbricht's work include Thyroid Cancer Diagnosis and Treatment (29 papers), Telomeres, Telomerase, and Senescence (17 papers) and Epigenetics and DNA Methylation (17 papers). Christopher B. Umbricht is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (29 papers), Telomeres, Telomerase, and Senescence (17 papers) and Epigenetics and DNA Methylation (17 papers). Christopher B. Umbricht collaborates with scholars based in United States, Switzerland and China. Christopher B. Umbricht's co-authors include Martha A. Zeiger, Saraswati Sukumar, Leigh A. Henricksen, Marc S. Wold, Ella Evron, Jeffrey R. Marks, William H. Westra, Edward Gabrielson, Anne Ferguson and Douglas P. Clark and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Christopher B. Umbricht

79 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant replication protein A: expression, complex formation, and functional characterization

1994 539 citations Christopher B. Umbricht et al. profile →

Peers

Countries citing papers authored by Christopher B. Umbricht

Since Specialization

Citations

This map shows the geographic impact of Christopher B. Umbricht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Umbricht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Umbricht more than expected).

Fields of papers citing papers by Christopher B. Umbricht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher B. Umbricht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Umbricht. The network helps show where Christopher B. Umbricht may publish in the future.

Co-authorship network of co-authors of Christopher B. Umbricht

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher B. Umbricht. A scholar is included among the top collaborators of Christopher B. Umbricht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher B. Umbricht. Christopher B. Umbricht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ 2024 ·Breast Cancer Research ·Marija Debeljak, Soonweng Cho, Bradley M. Downs, Michael Considine, (unknown), Yongchun Wang, (unknown), William E. Grizzle, Katherine A. Hoadley, Charles F. Lynch, Brenda Y. Hernandez, P. J. van Diest, Wendy Cozen, Ann S. Hamilton, Debra Hawes, Edward Gabrielson, Ashley Cimino‐Mathews, Liliana Florea, Leslie Cope, Christopher B. Umbricht	0
2	miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2 2023 ·International Journal of Molecular Sciences ·Bonita H. Powell, Andrey Turchinovich, Yongchun Wang, Олеся Гололобова, Dominik Buschmann, Martha A. Zeiger, Christopher B. Umbricht, Kenneth W. Witwer	8
3	Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial 2022 ·Clinical Cancer Research ·Kala Visvanathan, Leslie Cope, Mary Jo Fackler, Michael Considine, Lori J. Sokoll, Lisa A. Carey, (unknown), James N. Ingle, Nancy U. Lin, Rita Nanda, Anna Maria Storniolo, (unknown), (unknown), (unknown), (unknown), (unknown), Michael Bates, Christopher B. Umbricht, Antonio C. Wolff, Saraswati Sukumar	12
4	Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors 2021 ·Clinical Epigenetics ·Bradley M. Downs, (unknown), Leslie Cope, Christopher B. Umbricht, Wen Ge Li, (unknown), Xiaokang Ke, Matthias Holdhoff, Chetan Bettegowda, (unknown), Saraswati Sukumar	12
5	DNA methylation markers predict recurrence-free interval in triple-negative breast cancer 2020 ·npj Breast Cancer ·Mary Jo Fackler, Soonweng Cho, Leslie Cope, Edward Gabrielson, Kala Visvanathan, Kathleen Wilsbach, (unknown), Charles F. Lynch, Jeffrey R. Marks, Joseph Geradts, Meredith M. Regan, Giuseppe Viale, Antonio C. Wolff, Saraswati Sukumar, Christopher B. Umbricht	21
6	TERT promoter mutation determines apoptotic and therapeutic responses of BRAF -mutant cancers to BRAF and MEK inhibitors: Achilles Heel 2020 ·Proceedings of the National Academy of Sciences ·Jie Tan, Rengyun Liu, Guangwu Zhu, Christopher B. Umbricht, Mingzhao Xing	31
7	Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines 2020 ·Thyroid ·(unknown), Timothy Gilpatrick, Yongchun Wang, Winston Timp, Christopher B. Umbricht, Martha A. Zeiger	21
8	Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study 2018 ·Breast Cancer Research and Treatment ·(unknown), Zeyad T. Sahli, Yongchun Wang, Antonio C. Wolff, Leslie Cope, Christopher B. Umbricht	35
9	Thyroid Nodule Diagnostic Markers in the Face of the New NIFTP Category: Time for a Reset? 2017 ·Thyroid ·Zeyad T. Sahli, Christopher B. Umbricht, Eric B. Schneider, Martha A. Zeiger	20
10	MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review 2015 ·Thyroid ·Patricia Aragon Han, Chien‐Hsiang Weng, (unknown), Neeraja Nagarajan, Eric B. Schneider, Christopher B. Umbricht, Kenneth W. Witwer, Martha A. Zeiger	57
11	Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer 2014 ·Cancer Research ·Mary Jo Fackler, Zoila A. Lopez‐Bujanda, Christopher B. Umbricht, Wei Wen Teo, Soonweng Cho, Zhe Zhang, Kala Visvanathan, Stacie C. Jeter, Pedram Argani, Chenguang Wang, Jaclyn P. Lyman, Marina De Brot, James N. Ingle, Judy C. Boughey, Kandace P. McGuire, Tari A. King, Lisa A. Carey, Leslie Cope, Antonio C. Wolff, Saraswati Sukumar	118
12	Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome? 2014 ·PLoS ONE ·Leslie Cope, Mary Jo Fackler, Zoila A. Lopez‐Bujanda, Antonio C. Wolff, Kala Visvanathan, Joe W. Gray, Saraswati Sukumar, Christopher B. Umbricht	20
13	HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression 2013 ·Cancer Research ·Nilay Shah, Kideok Jin, (unknown), Sunju Park, Helen Sadik, Soonweng Cho, Chirayu Goswami, Harikrishna Nakshatri, Rajnish A. Gupta, Howard Y. Chang, Zhe Zhang, Ashley Cimino‐Mathews, Leslie Cope, Christopher B. Umbricht, Saraswati Sukumar	76
14	DoesBRAFV600E Mutation Predict Aggressive Features in Papillary Thyroid Cancer? Results From Four Endocrine Surgery Centers 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Carol Li, Patricia Aragon Han, Kathleen C. Lee, (unknown), Amy Fox, Toni Beninato, (unknown), Benzon M. Dy, Thomas J. Sebo, Geoffrey B. Thompson, Clive S. Grant, Thomas J. Giordano, Paul G. Gauger, Gerard M. Doherty, Thomas J. Fahey, Justin A. Bishop, James R. Eshleman, Christopher B. Umbricht, Eric B. Schneider, Martha A. Zeiger	46
15	Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer? 2012 ·Surgery ·Kathleen C. Lee, Carol Li, Eric B. Schneider, Yongchun Wang, Helina Somervell, Matthew Krafft, Christopher B. Umbricht, Martha A. Zeiger	47
16	Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence 2011 ·Cancer Research ·Mary Jo Fackler, Christopher B. Umbricht, Danielle Williams, Pedram Argani, (unknown), Vanessa F. Merino, Wei Wen Teo, Zhe Zhang, Peng Huang, (unknown), Jeffrey R. Marks, Stephen P. Ethier, Joe W. Gray, Antonio C. Wolff, Leslie Cope, Saraswati Sukumar	159
17	Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer 2011 ·Cancer Biology & Therapy ·(unknown), (unknown), Ravi Anchoori, Vered Stearns, Christopher B. Umbricht, Saeed R. Khan	48
18	Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors 2008 ·Clinical Cancer Research ·Nijaguna B. Prasad, Helina Somervell, Ralph P. Tufano, Alan P.B. Dackiw, Michael R. Marohn, Joseph A. Califano, Yongchun Wang, William H. Westra, Douglas P. Clark, Christopher B. Umbricht, Steven K. Libutti, Martha A. Zeiger	66
19	Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer 2006 ·International Journal of Cancer ·Shuiying Hu, Dingxie Liu, Ralph P. Tufano, Kathryn A. Carson, Eli Rosenbaum, Yoram Cohen, Elizabeth H. Holt, Katja Kiseljak‐Vassiliades, Kerry J. Rhoden, Sara M. Tolaney, (unknown), Giovanni Tallini, William H. Westra, Christopher B. Umbricht, Martha A. Zeiger, Joseph A. Califano, Vasily Vasko, Mingzhao Xing	157
20	Quantitative Assessment of Promoter Methylation Profiles in Thyroid Neoplasms 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Mohammad Obaidul Hoque, Eli Rosenbaum, William H. Westra, Mingzhao Xing, Paul W. Ladenson, Martha A. Zeiger, David Sidransky, Christopher B. Umbricht	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact